Q1 2025 13F Holders as of 31 Mar 2025
-
Type / Class
-
Equity / Common Shares, without par value
-
Shares outstanding
-
8,333,333
-
Total 13F shares
-
2,822,207
-
Share change
-
+2,614,718
-
Total reported value
-
$6,885,740
-
Price per share
-
$2.44
-
Number of holders
-
19
-
Value change
-
+$6,475,156
-
Number of buys
-
8
-
Number of sells
-
6
Institutional Holders of Edesa Biotech, Inc. - Common Shares, without par value (EDSA) as of Q1 2025
As of 31 Mar 2025,
Edesa Biotech, Inc. - Common Shares, without par value (EDSA) was held by
19 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
2,822,207 shares.
The largest 10 holders included
Rubric Capital Management LP, Velan Capital Investment Management LP, Stonepine Capital Management, LLC, Nantahala Capital Management, LLC, COMMONWEALTH EQUITY SERVICES, LLC, GEODE CAPITAL MANAGEMENT, LLC, CIBC WORLD MARKET INC., CITADEL ADVISORS LLC, VANGUARD GROUP INC, and ROYAL BANK OF CANADA.
This page lists
19
institutional shareholders reporting positions in this security
for the Q1 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.